NCT07100171View on ClinicalTrials.gov

Evaluation of GM101 Injection in Patients With Parkinson's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

February 17, 2027

Study Completion Date

February 17, 2030

Conditions
Parkinson's Disease
Interventions
OTHER

Biological: GM101

Neurosurgical delivery of GM101 to the putamen

Trial Locations (1)

Unknown

RECRUITING

Xiangya Hospital, Central South University, Changsha

Sponsors
All Listed Sponsors
lead

Genemagic Biosciences Co., Ltd

INDUSTRY